Role of the Cell Adhesome in Obesity-related Liver Diseases

细胞粘附体在肥胖相关肝病中的作用

基本信息

  • 批准号:
    10435482
  • 负责人:
  • 金额:
    $ 50.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1995
  • 资助国家:
    美国
  • 起止时间:
    1995-07-01 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY: A consequence of modernization is that people have adopted diets for which they are poorly adapted and live inactive lifestyles. This has resulted in dramatic increases in obesity, dyslipidemias, Type 2 diabetes, as well as other aggregates of the Metabolic Syndrome. Metabolic dysregulation of the liver is an early and prominent defect in the sequalae that lead to these conditions. A primary defect evident in the liver is a selective insulin resistance characterized by an impairment in insulin suppression of endogenous glucose production (EGP), but intact lipogenesis and lipid storage. This creates impaired regulation of blood glucose and an unhealthy accumulation of fat in the liver. Liver fibrosis is closely correlated to insulin resistance. We have compelling evidence that the cell “adhesome” couples changes in liver extracellular matrix to insulin resistance. The adhesome consists of integrin αβ heterodimers that transmit extracellular signals to protein complexes necessary for cells to adapt to their environment. We found that disruption of the adhesome either by disrupting the integrin α1 subunit or by deletion of the integrin-linked kinase (ILK) in the cell prevents fatty liver in obese mice. Interestingly, only ILK deletion prevents resistance to insulin suppression of GP. The proposed studies will define how the cell adhesome is coupled to hepatic metabolic regulation. Studies will use genetic mouse models to test the hypotheses that i) deleterious effects of ILK in the liver of diet-induced obese mice require that it complex with binding partners, PINCH and parvin; ii) ILK deletion reverses pre-existing fatty liver and IR in diet- induced obese mice; and iii) ILK requires Itgβ1 for its metabolic effects in DIO mice. These hypotheses will be addressed using isotopic methods to measure fatty acid synthesis and liver fatty acid uptake, triglyceride formation and export, and glucose fluxes in catheterized, conscious genetic mouse models. Hepatocytes will be isolated from these mouse models to define mechanisms that are particularly complex in the whole organism. Biochemical and histological analyses will identify pathways and regulatory mechanisms involved in metabolic regulation of nutrient fluxes by the cell adhesome of lean and diet-induced obese mice. Functional tests of the endoplasmic reticulum and mitochondria will define the role of these systems essential to fatty acid synthesis and nutrient oxidation, respectively. These studies will define the role of the cell adhesome in obesity-related liver metabolic disease and it will identify potential targets for treating the metabolic effects of obesity on the liver.
项目概要: 现代化的一个后果是,人们采用了他们所需要的饮食。 适应性差,生活方式不活跃。这导致了肥胖症的急剧增加, 血脂异常、2型糖尿病以及代谢综合征的其他聚集体。 肝脏的代谢失调是后遗症中的早期和突出缺陷, 了以下条件肝脏的一个主要缺陷是选择性胰岛素抵抗 以内源性葡萄糖产生的胰岛素抑制受损为特征 (EGP),但完整的脂肪生成和脂质储存。这造成血液调节受损 葡萄糖和肝脏中不健康的脂肪堆积。肝纤维化与 胰岛素抵抗我们有令人信服的证据表明,细胞“粘附体”夫妇的变化, 肝脏细胞外基质与胰岛素抵抗。粘附体由整合素αβ组成 异二聚体,其将细胞外信号传递到细胞所必需的蛋白质复合物, 适应他们的环境。我们发现,破坏粘附体, 整合素α1亚基或通过缺失细胞中的整合素连接激酶(ILK)来预防脂肪肝 在肥胖的老鼠身上。有趣的是,只有ILK缺失防止GP对胰岛素抑制的抗性。 拟议的研究将确定细胞粘附体如何与肝代谢偶联, 调控研究将使用遗传小鼠模型来测试以下假设:i)有害 ILK在饮食诱导的肥胖小鼠肝脏中的作用需要它与结合 ii)ILK缺失逆转饮食中预先存在的脂肪肝和IR- 诱导的肥胖小鼠;和iii)ILK需要Itgβ1用于其在DIO小鼠中的代谢作用。这些 假设将使用同位素方法来测量脂肪酸合成和肝脏 脂肪酸摄取、甘油三酯形成和输出,以及导管插入后的葡萄糖通量, 有意识的遗传小鼠模型。将从这些小鼠模型中分离肝细胞, 定义了整个生物体中特别复杂的机制。生化和 组织学分析将确定参与代谢的途径和调节机制, 瘦小鼠和饮食诱导的肥胖小鼠的细胞粘附体对营养流的调节。 内质网和线粒体的功能测试将确定这些的作用, 系统必需的脂肪酸合成和营养氧化分别。这些研究将 确定细胞粘附体在肥胖相关的肝脏代谢疾病中的作用, 治疗肥胖对肝脏代谢影响的潜在靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID H WASSERMAN其他文献

DAVID H WASSERMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID H WASSERMAN', 18)}}的其他基金

Administrative
行政的
  • 批准号:
    10588960
  • 财政年份:
    2023
  • 资助金额:
    $ 50.63万
  • 项目类别:
Vanderbilt Center for Metabolic Phenotyping in Live Models of Obesity and Diabetes
范德比尔特肥胖和糖尿病活体模型代谢表型中心
  • 批准号:
    10588959
  • 财政年份:
    2023
  • 资助金额:
    $ 50.63万
  • 项目类别:
Mouse Exercise and Metabolic Phenotyping Core
小鼠运动和代谢表型核心
  • 批准号:
    10242069
  • 财政年份:
    2019
  • 资助金额:
    $ 50.63万
  • 项目类别:
Mouse Exercise and Metabolic Phenotyping Core
小鼠运动和代谢表型核心
  • 批准号:
    10468246
  • 财政年份:
    2019
  • 资助金额:
    $ 50.63万
  • 项目类别:
Mouse Exercise and Metabolic Phenotyping Core
小鼠运动和代谢表型核心
  • 批准号:
    10677757
  • 财政年份:
    2019
  • 资助金额:
    $ 50.63万
  • 项目类别:
Mouse Exercise and Metabolic Phenotyping Core
小鼠运动和代谢表型核心
  • 批准号:
    10018900
  • 财政年份:
    2019
  • 资助金额:
    $ 50.63万
  • 项目类别:
Exercise and Fuel Metabolism
运动和燃料代谢
  • 批准号:
    8447691
  • 财政年份:
    2012
  • 资助金额:
    $ 50.63万
  • 项目类别:
Exercise and Fuel Metabolism
运动和燃料代谢
  • 批准号:
    8006764
  • 财政年份:
    2010
  • 资助金额:
    $ 50.63万
  • 项目类别:
Vanderbilt Mouse Metabolic Phenotyping Center
范德比尔特小鼠代谢表型中心
  • 批准号:
    7930013
  • 财政年份:
    2009
  • 资助金额:
    $ 50.63万
  • 项目类别:
ADMINISTRATIVE CORE
行政核心
  • 批准号:
    7638637
  • 财政年份:
    2008
  • 资助金额:
    $ 50.63万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 50.63万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 50.63万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.63万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.63万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 50.63万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.63万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 50.63万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 50.63万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 50.63万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.63万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了